Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $106.1000 (-1.53%) ($105.6000 - $106.1000) on Mon. Apr. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.57% (three month average) | RSI | 44 | Latest Price | $106.1000(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.8% a day on average for past five trading days. | Weekly Trend | LGND declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(60%) IWM(58%) IWC(56%) IWN(56%) | Factors Impacting LGND price | LGND will decline at least -1.785% in a week (0% probabilities). VIXM(-24%) UUP(-20%) VXX(-16%) TBT(-8%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.785% (StdDev 3.57%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $112.42 | 5 Day Moving Average | $110.41(-3.9%) | 10 Day Moving Average | $113.15(-6.23%) | 20 Day Moving Average | $112.42(-5.62%) | To recent high | -24.3% | To recent low | 11.3% | Market Cap | $1.705b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |